Market revenue in 2020 | USD 392.7 million |
Market revenue in 2028 | USD 680.9 million |
Growth rate | 7.1% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables, Services |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 60.17% in 2024. Horizon Databook has segmented the Japan infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
The infectious respiratory disease diagnostics market in Japan is estimated to witness the significant growth during the forecast period owing to the presence of well-established public healthcare system, trained public health workers, and efficient healthcare services in educational centers in the country.
These factors have significantly contributed to the rapidly reducing mortality rates due to infectious diseases. Key factors driving the growth of the market in this country include high prevalence of infectious respiratory diseases, rise in awareness about nucleic acid testing, and increase in geriatric population that is susceptible to infectious diseases.
The country performed around 15 million tests, as of June 2021. Furthermore, as of March 2021, around 40,000 PCR tests are being conducted per day. This significant data is indicative of the market growth in Japan. Increasing approval of diagnostic products for COVID-19 by healthcare authority of Japan, to increase testing capacity in the country, is boosting market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Japan infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account